NASDAQ:IVVD
Invivyd, Inc. Stock News
$2.42
-0.110 (-4.35%)
At Close: May 09, 2024
Invivyd to Host Conference Call Discussing First Quarter 2024 Financial Results and Business Highlights
05:13pm, Thursday, 02'nd May 2024
WALTHAM, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that
3 Groundbreaking Biotech Stocks to Invest in Now
12:35pm, Monday, 29'th Jan 2024
Biotechnology companies are intriguing investment vehicles because they are part of a pretty speculative industry that allows investors to grow their investments rapidly — if they pick a company bef
All You Need to Know About Invivyd, Inc. (IVVD) Rating Upgrade to Strong Buy
01:32pm, Friday, 12'th Jan 2024
Invivyd, Inc. (IVVD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Invivyd Stock More Than Doubled Last Week. Is It Too Late to Buy?
05:29am, Saturday, 23'rd Dec 2023
Invivyd is developing an experimental antibody treatment to prevent COVID-19 in immunocompromised patients. An estimated 9 million immunocompromised patients in the U.S. don't respond strongly enough
Invivyd (IVVD) Surges on Positive Data From COVID-19 Study
01:32pm, Tuesday, 19'th Dec 2023
Invivyd (IVVD) reports positive initial data from the phase III CANOPY study on VYD222 for the prevention of symptomatic COVID-19. Stock shoots up on the news.
Invivyd, Inc. (IVVD) Q3 2023 Earnings Call Transcript
09:41pm, Sunday, 12'th Nov 2023
Invivyd, Inc. (NASDAQ:IVVD ) Q3 2023 Earnings Conference Call November 9, 2023 4:30 PM ET Corporate Participants Scott Young - SVP, Investor Relations and Corporate Communications Dave Hering - Chief
Invivyd to Host Conference Call Discussing Third Quarter 2023 Financial Results and Business Highlights
04:01pm, Thursday, 02'nd Nov 2023
WALTHAM, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a clinical-stage biopharmaceutical company on a mission to protect the vulnerable from serious viral infectious diseases
Invivyd to Participate in Upcoming Investor Conferences
04:01pm, Tuesday, 31'st Oct 2023
WALTHAM, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a clinical-stage biopharmaceutical company on a mission to protect the vulnerable from serious viral infectious diseases
7 Biotech Stocks to Sell in September Before They Crash & Burn
08:17pm, Wednesday, 06'th Sep 2023
Investing in biotech stocks is not for the meek. Losses can be very large and occur very quickly.
Invivyd (IVVD) Stock Rises 18% in 3 Months: Here's Why
02:17pm, Tuesday, 29'th Aug 2023
Invivyd's (IVVD) shares rallied almost 18% over the past three months, owing to promising developments in its monoclonal antibody candidate, VYD222, designed to prevent symptomatic COVID-19 infection.
Invivyd, Inc. (IVVD) Q2 2023 Earnings Call Transcript
10:47pm, Saturday, 12'th Aug 2023
Invivyd, Inc. (NASDAQ:IVVD ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Gabriella Linville-Engler - Investor Relations Dave Hering - Chief Financial Officer Pete
Invivyd to Host Conference Call Discussing Second Quarter 2023 Financial Results and Business Highlights
04:01pm, Thursday, 03'rd Aug 2023
WALTHAM, Mass., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a clinical-stage biopharmaceutical company on a mission to protect the vulnerable from serious viral infectious diseases
Invivyd to Participate at H.C. Wainwright's BioConnect Investor Conference
04:01pm, Tuesday, 25'th Apr 2023
WALTHAM, Mass., April 25, 2023 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) a clinical-stage biopharmaceutical company on a mission to protect the vulnerable from serious viral infectious diseases
Invivyd, Inc (IVVD) Q4 2022 Earnings Call Transcript
10:49am, Saturday, 25'th Mar 2023
Invivyd, Inc (NASDAQ:IVVD ) Q4 2022 Earnings Conference Call March 23, 2023 4:30 PM ET Company Participants Kyra Faircloth - Investor Relations Dave Hering - Chief Executive Officer Pete Schmidt - Chi
Invivyd to Host Conference Call Discussing Full Year 2022 Financial Results and Business Highlights
07:00am, Thursday, 16'th Mar 2023
WALTHAM, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) a clinical-stage biopharmaceutical company on a mission to protect the vulnerable from serious viral infectious diseases
